{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:44:40Z","timestamp":1793403880643,"version":"4.5.0"},"reference-count":59,"publisher":"Bentham Science Publishers Ltd.","issue":"8","funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research","doi-asserted-by":"publisher","award":["02(0400)\/21\/EMR-II"],"award-info":[{"award-number":["02(0400)\/21\/EMR-II"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MRMC"],"published-print":{"date-parts":[[2023,5,10]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract:<\/jats:title>\n                    <jats:p>One of the most fatal infectious diseases, malaria, still poses a threat to about half of the world's population and is the leading cause of death worldwide. The use of artemisinin-based combination therapy has helped to significantly reduce the number of deaths caused by malaria, but the emergence of drug resistance threatens to undo this gain. In a bid to boost adherence, several new combination therapies with effectiveness against drug-resistant parasites are currently being tested in clinical settings. Nevertheless, notwithstanding these gains, malaria must be completely eradicated by a concerted international effort on several fronts. Quinoline-based compounds were the cornerstone of malaria chemotherapy until recently when resistance to these drugs severely hampered efforts to achieve a \"Zero Malaria\" world. The inappropriate use of available antimalarials is one of the factors responsible for resistance development and treatment failure, warranting the search for new chemical entities and alternative approaches to combat this threat. A vast number of solutions have emerged and one of them, quinoline-hybridization, is an effective method for introducing structural diversity, resulting in molecules with improved biological activities, reduced drug resistance, fewer drug-drug interactions, and improved safety and pharmacokinetic profiles. Choosing the ideal target combination and achieving a balanced activity toward them while preserving drug-like properties are the key challenges in the development of molecular hybrids. This review examines the highlights of quinoline hybridization, with some of the hybrids exhibiting remarkable in vitro and in vivo activities, emphasizing that it is a useful method for developing new anti-malarial lead compounds.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1389557523666221221140716","type":"journal-article","created":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T02:36:31Z","timestamp":1671676591000},"page":"898-916","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A Glimpse at the Quinoline-Hybridization Approach for the Development\nof New Antimalarials"],"prefix":"10.2174","volume":"23","author":[{"given":"Sukhbir","family":"Kaur","sequence":"first","affiliation":[{"name":"Department of Chemistry, Guru Nanak Dev University, Amritsar, 143005, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanjot","family":"Kaur","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Guru Nanak Dev University, Amritsar, 143005, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandeep","family":"Arora","sequence":"additional","affiliation":[{"name":"Department of Natural and Applied\nSciences, University of Dubuque, Dubuque, IA, 52002, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipan","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Guru Nanak Dev University, Amritsar, 143005, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"5950","DOI":"10.1016\/j.bmc.2014.09.009","volume":"22","author":"Sinha M.","year":"2014","unstructured":"Sinha M.; Dola V.R.; Soni A.; Agarwal P.; Srivastava K.; Haq W.; Puri S.K.; Katti S.B.; Synthesis of chiral chloroquine and its analogues as antimalarial agents. Bioorg Med Chem 2014,22(21),5950-5960","journal-title":"Bioorg Med Chem"},{"key":"ref=2","unstructured":"World malaria report 2021, Geneva: world health organisation. 2020. Available from:"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/j.1747-0285.2011.01115.x","volume":"78","author":"Manohar S.","year":"2011","unstructured":"Manohar S.; Khan S.I.; Rawat D.S.; Synthesis of 4-aminoquinoline-1,2,3-triazole and 4-aminoquinoline-1,2,3-triazole-1,3,5-triazine Hybrids as Potential Antimalarial Agents. Chem Biol Drug Des 2011,78(1),124-136","journal-title":"Chem Biol Drug Des"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1021\/jm301654b","volume":"56","author":"P\u00e9rez B.C.","year":"2013","unstructured":"P\u00e9rez B.C.; Teixeira C.; Albuquerque I.S.; Gut J.; Rosenthal P.J.; Gomes J.R.B.; Prud\u00eancio M.; Gomes P.; N-cinnamoylated chloroquine analogues as dual-stage antimalarial leads. J Med Chem 2013,56(2),556-567","journal-title":"J Med Chem"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"28171","DOI":"10.1039\/C4RA16032K","volume":"5","author":"Manohar S.","year":"2015","unstructured":"Manohar S.; Satya Pavan V.; Taylor D.; Kumar D.; Ponnan P.; Wiesner L.; Rawat D.S.; Highly active 4-aminoquinoline\u2013pyrimidine based molecular hybrids as potential next generation antimalarial agents. RSC Advances 2015,5(36),28171-28186","journal-title":"RSC Advances"},{"key":"ref=6a","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1039\/c2md20238g","volume":"3","author":"Mott B.T.","year":"2012","unstructured":"Mott B.T.; Cheng K.C.C.; Guha R.; Kommer V.P.; Williams D.L.; Vermeire J.J.; Cappello M.; Maloney D.J.; Rai G.; Jadhav A.; Simeonov A.; Inglese J.; Posner G.H.; Thomas C.J.; A furoxan\u2013amodiaquine hybrid as a potential therapeutic for three parasitic diseases. MedChemComm 2012,3(12),1505-1511","journal-title":"MedChemComm"},{"key":"ref=6b","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/sci4030030","volume":"4","author":"Mahajan A.","year":"2022","unstructured":"Mahajan A.; Singh H.; Singh A.; Agrawal D.K.; Arora A.; Chundawat T.S.; Trifluoromethylated quinolone-hydantoin hybrids: synthesis and antibacterial evaluation. Sci 2022,4(3),30","journal-title":"Sci"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1021\/jm990437l","volume":"43","author":"Egan T.J.","year":"2000","unstructured":"Egan T.J.; Hunter R.; Kaschula C.H.; Marques H.M.; Misplon A.; Walden J.; Structure-function relationships in aminoquinolines: effect of amino and chloro groups on quinoline-hematin complex formation, inhibition of \u03b2-hematin formation, and antiplasmodial activity. J Med Chem 2000,43(2),283-291","journal-title":"J Med Chem"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1021\/jm301076q","volume":"56","author":"Cornut D.","year":"2013","unstructured":"Cornut D.; Lemoine H.; Kanishchev O.; Okada E.; Albrieux F.; Beavogui A.H.; Bienvenu A.L.; Picot S.; Bouillon J.P.; M\u00e9debielle M.; Incorporation of a 3-(2,2,2-trifluoroethyl)-\u03b3-hydroxy-\u03b3-lactam motif in the side chain of 4-aminoquinolines. Syntheses and antimalarial activities. J Med Chem 2013,56(1),73-83","journal-title":"J Med Chem"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"105676","DOI":"10.1039\/C6RA14016E","volume":"6","author":"Kondaparla S.","year":"2016","unstructured":"Kondaparla S.; Soni A.; Manhas A.; Srivastava K.; Puri S.K.; Katti S.B.; Synthesis and antimalarial activity of new 4-aminoquinolines active against drug resistant strains. RSC Advances 2016,6(107),105676-105689","journal-title":"RSC Advances"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ejmech.2013.05.023","volume":"66","author":"Pandey S.","year":"2013","unstructured":"Pandey S.; Agarwal P.; Srivastava K.; RajaKumar, S.; Puri, S.K.; Verma, P.; Saxena, J.K.; Sharma, A.; Lal, J.; Chauhan, P.M.S. Synthesis and bioevaluation of novel 4-aminoquinoline-tetrazole derivatives as potent antimalarial agents. Eur J Med Chem 2013,66,69-81","journal-title":"Eur J Med Chem"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1039\/C6MD00084C","volume":"7","author":"Singh K.","year":"2016","unstructured":"Singh K.; Kaur T.; Pyrimidine-based antimalarials: design strategies and antiplasmodial effects. MedChemComm 2016,7(5),749-768","journal-title":"MedChemComm"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1021\/ml3000808","volume":"3","author":"Manohar S.","year":"2012","unstructured":"Manohar S.; Rajesh U.C.; Khan S.I.; Tekwani B.L.; Rawat D.S.; Novel 4-aminoquinoline-pyrimidine based hybrids with improved in vitro and in vivo antimalarial activity. ACS Med Chem Lett 2012,3(7),555-559","journal-title":"ACS Med Chem Lett"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1021\/jm4014778","volume":"57","author":"Singh K.","year":"2014","unstructured":"Singh K.; Kaur H.; Smith P.; de Kock C.; Chibale K.; Balzarini J.; Quinoline-pyrimidine hybrids: synthesis, antiplasmodial activity, SAR, and mode of action studies. J Med Chem 2014,57(2),435-448","journal-title":"J Med Chem"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ejmech.2017.02.024","volume":"129","author":"Maurya S.S.","year":"2017","unstructured":"Maurya S.S.; Khan S.I.; Bahuguna A.; Kumar D.; Rawat D.S.; Synthesis, antimalarial activity, heme binding and docking studies of N -substituted 4-aminoquinoline-pyrimidine molecular hybrids. Eur J Med Chem 2017,129,175-185","journal-title":"Eur J Med Chem"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ejmech.2018.11.021","volume":"162","author":"Maurya S.S.","year":"2019","unstructured":"Maurya S.S.; Bahuguna A.; Khan S.I.; Kumar D.; Kholiya R.; Rawat D.S.; N-Substituted aminoquinoline-pyrimidine hybrids: Synthesis, in vitro antimalarial activity evaluation and docking studies. Eur J Med Chem 2019,162,277-289","journal-title":"Eur J Med Chem"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"20729","DOI":"10.1039\/C4RA02276A","volume":"4","author":"Thakur A.","year":"2014","unstructured":"Thakur A.; Khan S.I.; Rawat D.S.; Synthesis of piperazine tethered 4-aminoquinoline-pyrimidine hybrids as potent antimalarial agents. RSC Advances 2014,4(40),20729-20736","journal-title":"RSC Advances"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"63655","DOI":"10.1039\/C4RA09768H","volume":"4","author":"Kumar D.","year":"2014","unstructured":"Kumar D.; Khan S.I.; Tekwani B.L.; Ponnan P.; Rawat D.S.; Synthesis, antimalarial activity, heme binding and docking studies of 4-aminoquinoline\u2013pyrimidine based molecular hybrids. RSC Advances 2014,4(109),63655-63669","journal-title":"RSC Advances"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.1039\/C5NJ00094G","volume":"39","author":"Tripathi M.","year":"2015","unstructured":"Tripathi M.; Khan S.I.; Thakur A.; Ponnan P.; Rawat D.S.; 4-Aminoquinoline-pyrimidine-aminoalkanols: synthesis, in vitro antimalarial activity, docking studies and ADME predictions. New J Chem 2015,39(5),3474-3483","journal-title":"New J Chem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ejmech.2012.03.007","volume":"52","author":"Singh K.","year":"2012","unstructured":"Singh K.; Kaur H.; Chibale K.; Balzarini J.; Little S.; Bharatam P.V.; 2-Aminopyrimidine based 4-aminoquinoline anti-plasmodial agents. Synthesis, biological activity, structure\u2013activity relationship and mode of action studies. Eur J Med Chem 2012,52,82-97","journal-title":"Eur J Med Chem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.ejmech.2013.05.046","volume":"66","author":"Singh K.","year":"2013","unstructured":"Singh K.; Kaur H.; Chibale K.; Balzarini J.; Synthesis of 4-aminoquinoline\u2013pyrimidine hybrids as potent antimalarials and their mode of action studies. Eur J Med Chem 2013,66,314-323","journal-title":"Eur J Med Chem"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ejmech.2018.02.021","volume":"148","author":"Chopra R.","year":"2018","unstructured":"Chopra R.; Chibale K.; Singh K.; Pyrimidine-chloroquinoline hybrids: Synthesis and antiplasmodial activity. Eur J Med Chem 2018,148,39-53","journal-title":"Eur J Med Chem"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ejmech.2017.03.007","volume":"131","author":"Kholiya R.","year":"2017","unstructured":"Kholiya R.; Khan S.I.; Bahuguna A.; Tripathi M.; Rawat D.S.; N -Piperonyl substitution on aminoquinoline-pyrimidine hybrids: Effect on the antiplasmodial potency. Eur J Med Chem 2017,131,126-140","journal-title":"Eur J Med Chem"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.ejps.2012.09.019","volume":"47","author":"Lombard M.C.","year":"2012","unstructured":"Lombard M.C.; N\u2019Da D.D.; Breytenbach J.C.; Kolesnikova N.I.; Tran Van Ba C.; Wein S.; Norman J.; Denti P.; Vial H.; Wiesner L.; Antimalarial and anticancer activities of artemisinin\u2013quinoline hybrid-dimers and pharmacokinetic properties in mice. Eur J Pharm Sci 2012,47(5),834-841","journal-title":"Eur J Pharm Sci"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1021\/acsmedchemlett.9b00669","volume":"11","author":"Pepe D.A.","year":"2020","unstructured":"Pepe D.A.; Toumpa D.; Andr\u00e9-Barr\u00e8s C.; Menendez C.; Mouray E.; Baltas M.; Grellier P.; Papaioannou D.; Athanassopoulos C.M.; Synthesis of novel G factor or chloroquine-artemisinin hybrids and conjugates with potent antiplasmodial activity. ACS Med Chem Lett 2020,11(5),921-927","journal-title":"ACS Med Chem Lett"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/j.bmcl.2011.01.103","volume":"21","author":"Lombard M.C.","year":"2011","unstructured":"Lombard M.C.; N\u2019Da D.D.; Breytenbach J.C.; Smith P.J.; Lategan C.A.; Synthesis, in vitro antimalarial and cytotoxicity of artemisinin-aminoquinoline hybrids. Bioorg Med Chem Lett 2011,21(6),1683-1686","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"536","DOI":"10.3390\/ph15050536","volume":"15","author":"Chowdhary S.","year":"2022","unstructured":"Chowdhary S.; Shalini; Arora, A.; Kumar, V. A Mini review on isatin, an anticancer scaffold with potential activities against neglected tropical diseases (NTDs). Pharmaceuticals (Basel) 2022,15(5),536","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.ejmech.2013.01.032","volume":"62","author":"Raj R.","year":"2013","unstructured":"Raj R.; Singh P.; Singh P.; Gut J.; Rosenthal P.J.; Kumar V.; Azide-alkyne cycloaddition en route to 1 H -1,2,3-triazole-tethered 7-chloroquinoline-isatin chimeras: Synthesis and antimalarial evaluation. Eur J Med Chem 2013,62,590-596","journal-title":"Eur J Med Chem"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.bmcl.2013.12.109","volume":"24","author":"Raj R.","year":"2014","unstructured":"Raj R.; Gut J.; Rosenthal P.J.; Kumar V.; 1H-1,2,3-Triazole-tethered isatin-7-chloroquinoline and 3-hydroxy-indole-7-chloroquinoline conjugates: Synthesis and antimalarial evaluation. Bioorg Med Chem Lett 2014,24(3),756-759","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/cbdd.12273","volume":"83","author":"Raj R.","year":"2014","unstructured":"Raj R.; Biot C.; Carr\u00e8re-Kremer S.; Kremer L.; Gu\u00e9rardel Y.; Gut J.; Rosenthal P.J.; Forge D.; Kumar V.; 7-chloroquinoline-isatin conjugates: antimalarial, antitubercular, and cytotoxic evaluation. Chem Biol Drug Des 2014,83(5),622-629","journal-title":"Chem Biol Drug Des"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.ejmech.2014.07.064","volume":"84","year":"2014","unstructured":"Nisha; Gut, J.; Rosenthal, P.J.; Kumar, V. \u03b2-amino-alcohol tethered 4-aminoquinoline-isatin conjugates: Synthesis and antimalarial evaluation. Eur J Med Chem 2014,84,566-573","journal-title":"Eur J Med Chem"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/17460441.2019.1573812","volume":"14","author":"Rani A.","year":"2019","unstructured":"Rani A.; Anand A.; Kumar K.; Kumar V.; Recent developments in biological aspects of chalcones: the odyssey continues. Expert Opin Drug Discov 2019,14(3),249-288","journal-title":"Expert Opin Drug Discov"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ejmech.2015.03.045","volume":"95","author":"Raj R.","year":"2015","unstructured":"Raj R.; Saini A.; Gut J.; Rosenthal P.J.; Kumar V.; Synthesis and in vitro antiplasmodial evaluation of 7-chloroquinoline\u2013chalcone and 7-chloroquinoline\u2013ferrocenylchalcone conjugates. Eur J Med Chem 2015,95,230-239","journal-title":"Eur J Med Chem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1007\/s00044-016-1509-y","volume":"25","author":"Smit F.J.","year":"2016","unstructured":"Smit F.J.; Bezuidenhout J.J.; Bezuidenhout C.C.; N\u2019Da D.D.; Synthesis and in vitro biological activities of ferrocenyl\u2013chalcone amides. Med Chem Res 2016,25(4),568-584","journal-title":"Med Chem Res"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.ejmech.2017.07.041","volume":"138","author":"Kumar S.","year":"2017","unstructured":"Kumar S.; Saini A.; Gut J.; Rosenthal P.J.; Raj R.; Kumar V.; 4-Aminoquinoline-chalcone\/- N-acetylpyrazoline conjugates: Synthesis and antiplasmodial evaluation. Eur J Med Chem 2017,138,993-1001","journal-title":"Eur J Med Chem"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ejmech.2014.07.048","volume":"84","author":"Raj R.","year":"2014","unstructured":"Raj R.; Mehra V.; Gut J.; Rosenthal P.J.; Wicht K.J.; Egan T.J.; Hopper M.; Wrischnik L.A.; Land K.M.; Kumar V.; Discovery of highly selective 7-chloroquinoline-thiohydantoins with potent antimalarial activity. Eur J Med Chem 2014,84,425-432","journal-title":"Eur J Med Chem"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/cbdd.12225","volume":"83","author":"Raj R.","year":"2014","unstructured":"Raj R.; Biot C.; Carr\u00e8re-Kremer S.; Kremer L.; Gu\u00e9rardel Y.; Gut J.; Rosenthal P.J.; Kumar V.; 4-Aminoquinoline-\u03b2-lactam conjugates: synthesis, antimalarial, and antitubercular evaluation. Chem Biol Drug Des 2014,83(2),191-197","journal-title":"Chem Biol Drug Des"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ejmech.2013.10.079","volume":"71","author":"Singh P.","year":"2014","unstructured":"Singh P.; Raj R.; Singh P.; Gut J.; Rosenthal P.J.; Kumar V.; Urea\/oxalamide tethered \u03b2-lactam-7-chloroquinoline conjugates: Synthesis and in vitro antimalarial evaluation. Eur J Med Chem 2014,71,128-134","journal-title":"Eur J Med Chem"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ejmech.2017.11.033","volume":"143","author":"Rani A.","year":"2018","unstructured":"Rani A.; Singh A.; Gut J.; Rosenthal P.J.; Kumar V.; Microwave-promoted facile access to 4-aminoquinoline-phthalimides: Synthesis and anti-plasmodial evaluation. Eur J Med Chem 2018,143,150-156","journal-title":"Eur J Med Chem"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"116159","DOI":"10.1016\/j.bmc.2021.116159","volume":"39","author":"Rani A.","year":"2021","unstructured":"Rani A.; Sharma A.; Legac J.; Rosenthal P.J.; Singh P.; Kumar V.; A trio of quinoline-isoniazid-phthalimide with promising antiplasmodial potential: Synthesis, in-vitro evaluation and heme-polymerization inhibition studies. Bioorg Med Chem 2021,39,116159","journal-title":"Bioorg Med Chem"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1021\/acsmedchemlett.9b00521","volume":"11","author":"Shalini L.","year":"2020","unstructured":"Shalini L.; Legac J.; Adeniyi A.A.; Kisten P.; Rosenthal P.J.; Singh P.; Kumar V.; Functionalized naphthalimide-4-aminoquinoline conjugates as promising antiplasmodials, with mechanistic insights. ACS Med Chem Lett 2020,11(2),154-161","journal-title":"ACS Med Chem Lett"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1021\/acsmedchemlett.0c00536","volume":"11","author":"Shalini K.","year":"2020","unstructured":"Shalini K.; Kumar S.; Gendrot M.; Fonta I.; Mosnier J.; Cele N.; Awolade P.; Singh P.; Pradines B.; Kumar V.; Amide tethered 4-aminoquinoline-naphthalimide hybrids: A new class of possible dual function antiplasmodials. ACS Med Chem Lett 2020,11(12),2544-2552","journal-title":"ACS Med Chem Lett"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"19086","DOI":"10.1039\/C6DT03175G","volume":"45","author":"Adams M.","year":"2016","unstructured":"Adams M.; Stringer T.; de Kock C.; Smith P.J.; Land K.M.; Liu N.; Tam C.; Cheng L.W.; Njoroge M.; Chibale K.; Smith G.S.; Bioisosteric ferrocenyl-containing quinolines with antiplasmodial and antitrichomonal properties. Dalton Trans 2016,45(47),19086-19095","journal-title":"Dalton Trans"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ejmech.2016.09.044","volume":"125","author":"Singh A.","year":"2017","unstructured":"Singh A.; Gut J.; Rosenthal P.J.; Kumar V.; 4-Aminoquinoline-ferrocenyl-chalcone conjugates: Synthesis and anti-plasmodial evaluation. Eur J Med Chem 2017,125,269-277","journal-title":"Eur J Med Chem"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"5736","DOI":"10.1021\/om300354x","volume":"31","author":"Herrmann C.","year":"2012","unstructured":"Herrmann C.; Salas P.F.; Cawthray J.F.; de Kock C.; Patrick B.O.; Smith P.J.; Adam M.J.; Orvig C.; 1\u2032-Disubstituted ferrocenyl carbohydrate chloroquine conjugates as potential antimalarials. Organometallics 2012,31(16),5736-5747","journal-title":"Organometallics"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"111963","DOI":"10.1016\/j.ejmech.2019.111963","volume":"187","year":"2020","unstructured":"Mini\u0107 A.; Van de Walle, T.; Van Hecke, K.; Combrinck, J.; Smith, P.J.; Chibale, K.; D\u2019hooghe, M. Design and synthesis of novel ferrocene-quinoline conjugates and evaluation of their electrochemical and antiplasmodium properties. Eur J Med Chem 2020,187,111963","journal-title":"Eur J Med Chem"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1021\/jm301422h","volume":"56","author":"Salas P.F.","year":"2013","unstructured":"Salas P.F.; Herrmann C.; Cawthray J.F.; Nimphius C.; Kenkel A.; Chen J.; de Kock C.; Smith P.J.; Patrick B.O.; Adam M.J.; Orvig C.; Structural characteristics of chloroquine-bridged ferrocenophane analogues of ferroquine may obviate malaria drug-resistance mechanisms. J Med Chem 2013,56(4),1596-1613","journal-title":"J Med Chem"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.ejmech.2014.11.065","volume":"90","author":"Mwande Maguene G.","year":"2015","unstructured":"Mwande Maguene G.; Lekana-Douki J.B.; Mouray E.; Bousquet T.; Grellier P.; Pellegrini S.; Toure Ndouo F.S.; Lebibi J.; P\u00e9linski L.; Synthesis and in vitro antiplasmodial activity of ferrocenyl aminoquinoline derivatives. Eur J Med Chem 2015,90,519-525","journal-title":"Eur J Med Chem"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"6443","DOI":"10.1039\/c2dt30077j","volume":"41","author":"Glans L.","year":"2012","unstructured":"Glans L.; Hu W.; J\u00f6st C.; de Kock C.; Smith P.J.; Haukka M.; Bruhn H.; Schatzschneider U.; Nordlander E.; Synthesis and biological activity of cymantrene and cyrhetrene 4-aminoquinoline conjugates against malaria, leishmaniasis, and trypanosomiasis. Dalton Trans 2012,41(21),6443-6450","journal-title":"Dalton Trans"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"3905","DOI":"10.1039\/C5DT03739E","volume":"45","author":"Ekengard E.","year":"2016","unstructured":"Ekengard E.; Kumar K.; Fogeron T.; de Kock C.; Smith P.J.; Haukka M.; Monari M.; Nordlander E.; Pentamethylcyclopentadienyl-rhodium and iridium complexes containing (N^N and N^O) bound chloroquine analogue ligands: synthesis, characterization and antimalarial properties. Dalton Trans 2016,45(9),3905-3917","journal-title":"Dalton Trans"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.biopha.2011.03.003","volume":"65","author":"de Souza N.B.","year":"2011","unstructured":"de Souza N.B.; Carmo A.M.L.; Lagatta D.C.; Alves M.J.M.; Fontes A.P.S.; Coimbra E.S.; da Silva A.D.; Abramo C.; 4-aminoquinoline analogues and its platinum (II) complexes as antimalarial agents. Biomed Pharmacother 2011,65(4),313-316","journal-title":"Biomed Pharmacother"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1021\/om300945c","volume":"32","author":"Li Y.","year":"2013","unstructured":"Li Y.; de Kock C.; Smith P.J.; Guzgay H.; Hendricks D.T.; Naran K.; Mizrahi V.; Warner D.F.; Chibale K.; Smith G.S.; Synthesis, characterization, and pharmacological evaluation of silicon-containing aminoquinoline organometallic complexes as antiplasmodial, antitumor, and antimycobacterial agents. Organometallics 2013,32(1),141-150","journal-title":"Organometallics"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"5224","DOI":"10.1021\/cr500642d","volume":"115","year":"2015","unstructured":"Adamczyk-Wo\u017aniak, A.; Borys, K.M.; Sporzy\u0144ski, A. Recent developments in the chemistry and biological applications of benzoxaboroles. Chem Rev 2015,115(11),5224-5247","journal-title":"Chem Rev"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"104733","DOI":"10.1016\/j.bioorg.2021.104733","volume":"109","author":"Saini A.","year":"2021","unstructured":"Saini A.; Kumar S.; Raj R.; Chowdhary S.; Gendrot M.; Mosnier J.; Fonta I.; Pradines B.; Kumar V.; Synthesis and antiplasmodial evaluation of 1H-1,2,3-triazole grafted 4-aminoquinoline-benzoxaborole hybrids and benzoxaborole analogues. Bioorg Chem 2021,109,104733","journal-title":"Bioorg Chem"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.bmc.2014.05.024","volume":"22","author":"Sinha M.","year":"2014","unstructured":"Sinha M.; Dola V.R.; Agarwal P.; Srivastava K.; Haq W.; Puri S.K.; Katti S.B.; Antiplasmodial activity of new 4-aminoquinoline derivatives against chloroquine resistant strain. Bioorg Med Chem 2014,22(14),3573-3586","journal-title":"Bioorg Med Chem"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"103094","DOI":"10.1016\/j.bioorg.2019.103094","volume":"91","author":"Bhagat S.","year":"2019","unstructured":"Bhagat S.; Arfeen M.; Das G.; Ramkumar M.; Khan S.I.; Tekwani B.L.; Bharatam P.V.; Design, synthesis and biological evaluation of 4-aminoquinoline-guanylthiourea derivatives as antimalarial agents. Bioorg Chem 2019,91,103094","journal-title":"Bioorg Chem"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"10245","DOI":"10.1021\/acs.jmedchem.7b01537","volume":"60","author":"Joshi M.C.","year":"2017","unstructured":"Joshi M.C.; Okombo J.; Nsumiwa S.; Ndove J.; Taylor D.; Wiesner L.; Hunter R.; Chibale K.; Egan T.J.; 4-Aminoquinoline antimalarials containing a benzylmethylpyridylmethylamine group are active against drug resistant Plasmodium falciparum and exhibit oral activity in mice. J Med Chem 2017,60(24),10245-10256","journal-title":"J Med Chem"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"4152","DOI":"10.1074\/jbc.M107285200","volume":"277","author":"Huy N.T.","year":"2002","unstructured":"Huy N.T.; Kamei K.; Yamamoto T.; Kondo Y.; Kanaori K.; Takano R.; Tajima K.; Hara S.; Clotrimazole binds to heme and enhances heme-dependent hemolysis: proposed antimalarial mechanism of clotrimazole. J Biol Chem 2002,277(6),4152-4158","journal-title":"J Biol Chem"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"6948","DOI":"10.1021\/jm300802s","volume":"55","author":"Gemma S.","year":"2012","unstructured":"Gemma S.; Camodeca C.; Sanna Coccone S.; Joshi B.P.; Bernetti M.; Moretti V.; Brogi S.; Bonache de Marcos M.C.; Savini L.; Taramelli D.; Basilico N.; Parapini S.; Rottmann M.; Brun R.; Lamponi S.; Caccia S.; Guiso G.; Summers R.L.; Martin R.E.; Saponara S.; Gorelli B.; Novellino E.; Campiani G.; Butini S.; Optimization of 4-aminoquinoline\/clotrimazole-based hybrid antimalarials: further structure-activity relationships, in vivo studies, and preliminary toxicity profiling. J Med Chem 2012,55(15),6948-6967","journal-title":"J Med Chem"}],"container-title":["Mini-Reviews in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389557523666221221140716","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/212093\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389557523666221221140716","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T23:55:48Z","timestamp":1692662148000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/212093\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,10]]},"references-count":59,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,5,10]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389557523666221221140716","relation":{},"ISSN":["1389-5575"],"issn-type":[{"value":"1389-5575","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,10]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-08-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}